Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,112.4
₹61,126 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹27,784.7
₹59,040 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,787.8
₹34,823 Cr
Pharmaceuticals & Drugs
₹892.1
₹17,534 Cr
Pharmaceuticals & Drugs
₹637.6
₹5,778 Cr
Pharmaceuticals & Drugs
₹341.7
₹3,823 Cr
Pharmaceuticals & Drugs
₹417.1
₹3,806 Cr
Pharmaceuticals & Drugs
₹113.4
₹2,912 Cr
Pharmaceuticals & Drugs
₹1,188.9
₹679 Cr
Pharmaceuticals & Drugs
₹47.7
₹135 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,112.4
₹12,706 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹892.1
₹6,419 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,787.8
₹4,532 Cr
Pharmaceuticals & Drugs
₹417.1
₹2,330 Cr
Pharmaceuticals & Drugs
₹637.6
₹1,968 Cr
Pharmaceuticals & Drugs
₹341.7
₹619 Cr
Pharmaceuticals & Drugs
₹113.4
₹192 Cr
Pharmaceuticals & Drugs
₹27,784.7
₹6,066 Cr
Pharmaceuticals & Drugs
₹1,188.9
₹365 Cr
Pharmaceuticals & Drugs
₹47.7
₹519 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,112.4
₹2,161 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,787.8
₹898 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹892.1
₹602 Cr
Pharmaceuticals & Drugs
₹637.6
₹228 Cr
Pharmaceuticals & Drugs
₹417.1
₹153 Cr
Pharmaceuticals & Drugs
₹341.7
₹141 Cr
Pharmaceuticals & Drugs
₹113.4
₹126 Cr
Pharmaceuticals & Drugs
₹27,784.7
₹1,285 Cr
Pharmaceuticals & Drugs
₹1,188.9
₹69 Cr
Pharmaceuticals & Drugs
₹47.7
₹7 Cr

You may also like the below Video Courses